Genetic evaluation of a combination therapy for the treatment of KRAS mutant lung adenocarcinoma

Información

Fecha: 17/01/2020
Hora 15:00
Lugar: Auditorio CNIO
Conferenciante Laura De Esteban
Procedencia Experimental Oncology Group, Molecular Oncology Programme
Supervised by Mariano Barbacid and Monica Musteanu, Experimental Oncology Group, Molecular Oncology Programme
Entrada libre hasta completar aforo